Posted by Michael Wonder on 18 Oct 2020
Pfizer to seek FDA approval for COVID-19 vaccine in November
16 October 2020 - US group and German partner BioNTech prepare to submit trial results next month.
Pfizer will apply for emergency US approval of the COVID-19 vaccine it is developing with Germany’s BioNTech in the third week of November, the pharma group said, assuming it receives positive results from its current trial.
Albert Bourla, Pfizer’s chief executive, said in an open letter that he wanted to “provide greater clarity around the development timelines” of the vaccine, which is being tested on some 38,000 people worldwide.
